A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma

Author: Bélanger Karl   MacDonald David   Cairncross Gregory   Gertler Stan   Forsyth Peter   Burdette-Radoux Susan   Bergeron Julie   Soulières Denis   Ludwin Samuel   Wainman Nancy   Eisenhauer Elizabeth  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.21, Iss.4, 2003-11, pp. : 473-480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content